$1.70 -$0.10 (-5.6%)

04:15 PM EDT on 04/03/20

Mallinckrodt plc (NYSE:MNK)

CAPS Rating: 1 out of 5

Current Price $1.70 Mkt Cap $143.2M
Open $1.77 P/E Ratio 0.00
Prev. Close $1.70 Div. (Yield) $0.00 (0.0%)
Daily Range $1.70 - $1.84 Volume 410,143
52-Wk Range $1.00 - $6.42 Avg. Daily Vol. 8,720,694

Caps

How do you think NYSE:MNK will perform against the market?

Add Stock to CAPS Watchlist

All Players

56 Outperform
32 Underperform
 

All-Star Players

6 Outperform
20 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:MNK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

domesticated (22.14)
Submitted December 17, 2013

Very undervalued spinoff.

Dosada123 (93.79)
Submitted May 24, 2017

Borrowed from jim chanos-- First, overpriced based on underlying fundamentals. (at time of writing P/E ratio of 43). Second, regulatory risk (think Valeant). Over 100% of operating profitability is from drug Acthar (although company disputes this… More

NYSE:MNK VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from players about MNK.

Recs

0
Member Avatar SmartAce (99.97) Submitted: 3/26/2020 12:42:48 PM : Underperform Start Price: $2.31 NYSE:MNK Score: +23.50

math teacher: I said to bring your protractor to class
boy with cowboy hat: I’m just a good old fashioned country boy, I ain’t need nothin fancy, this simple tractor should do the job just fine ma’am

Recs

0
Member Avatar jed71 (99.91) Submitted: 9/5/2019 12:40:09 PM : Underperform Start Price: $1.51 NYSE:MNK Score: -29.25

$700MM in debt set to mature in early 2020 with no hope of finding a suitor to help with refinancing. Company is considering bankruptcy.

Recs

1
Member Avatar Dosada123 (93.79) Submitted: 5/24/2017 3:11:21 AM : Underperform Start Price: $40.14 NYSE:MNK Score: +99.02

Borrowed from jim chanos-- First, overpriced based on underlying fundamentals. (at time of writing P/E ratio of 43). Second, regulatory risk (think Valeant). Over 100% of operating profitability is from drug Acthar (although company disputes this claim)- treatment per patient has gone from $40 to $35000 in the past 15 years. 8 billion of debt, with under 300 million of annualized operating income. Underlying Assumption-- If the debt is not worth 100 cents on the dollar, the stock is a zero.

Leaderboard

Find the members with the highest scoring picks in MNK.

Score Leader

bbguru300

bbguru300 (99.72) Score: +233.84

The Score Leader is the player with the highest score across all their picks in MNK.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
SimonSaysSell 98.01 4/8/2014 Underperform NS $61.31 -97.23% +34.71% +131.94 0 Comment
DTBoojum 32.93 5/8/2014 Underperform 5Y $76.77 -97.79% +32.23% +130.01 0 Comment
CamK05 54.91 3/16/2016 Underperform 3M $58.25 -97.08% +23.09% +120.17 0 Comment
lifeboy 68.77 12/8/2016 Underperform 5Y $51.73 -96.71% +10.50% +107.21 0 Comment
foolishfun4me 98.80 12/9/2016 Underperform 5Y $52.51 -96.76% +9.86% +106.62 0 Comment
numero9 36.12 4/5/2017 Underperform 5Y $44.01 -96.14% +5.03% +101.17 0 Comment
Ajormond 56.85 5/8/2017 Underperform 5Y $48.03 -96.46% +3.50% +99.96 0 Comment
Dosada123 93.79 5/24/2017 Underperform 5Y $40.14 -95.76% +3.26% +99.02 1 Comment
nchan01 58.58 6/7/2017 Underperform 3Y $39.96 -95.75% +1.95% +97.69 0 Comment
patatepoil6 99.91 8/1/2017 Underperform 5Y $45.92 -96.30% +0.28% +96.58 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for MNK.